The Agency did not request the initiation of any new studies and has suggested an end-of-review conference between Wyeth and the FDA to address the remaining issues.

• FDA并没有要求惠氏进行任何新的临床研究，反而提出要与惠氏一起召开审查总结会，以解决上述遗留问题。